Great Lakes Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Buy
+51,611
New +$595K ﹤0.01% 606
2019
Q3
Sell
-24,111
Closed -$3.09M 566
2019
Q2
$3.09M Buy
+24,111
New +$3.35M 0.07% 285
2018
Q4
Sell
-36,317
Closed -$8.05M 598
2018
Q3
$8.05M Sell
36,317
-2,743
-7% -$556K 0.18% 130
2018
Q2
$6.26M Buy
39,060
+518
+1% +$66.2K 0.15% 159
2018
Q1
$3.6M Buy
+38,542
New +$2.88M 0.09% 224
2014
Q1
Sell
-24,331
Closed -$636K 381
2013
Q4
$636K Buy
24,331
+9,738
+67% +$250K 0.03% 207
2013
Q3
$392K Sell
14,593
-188
-1% -$5.03K 0.02% 275
2013
Q2
$381K Buy
+14,781
New +$388K 0.02% 272

Other funds holding MED

Great Lakes Advisors's MED Position: Q2 2026 in Review

Great Lakes Advisors opened a new position in Medifast (MED) in Q2 2026: 51,611 shares worth $548K. The stake represents ﹤0.01% of the portfolio and ranks #606 among its holdings. This is a return to the name: Great Lakes Advisors previously reported a position in MED as recently as Q2 2019.

Great Lakes Advisors first reported a position in MED in Q2 2013 and has held it in 8 quarters since. The position peaked at $8.05M in Q3 2018. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Great Lakes Advisors held 51,611 shares of Medifast worth $548K as of Q2 2026.
  • Medifast was a new Great Lakes Advisors position in Q2 2026.
  • Medifast made up ﹤0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #606 holding.
  • Great Lakes Advisors first reported a position in Medifast in Q2 2013 and has held it in 8 quarters since.
  • Great Lakes Advisors's Medifast position peaked at $8.05M in Q3 2018.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.